July 25, 2018
Danish insulin maker Novo Nordisk A/S on Wednesday urged a New Jersey federal judge to dismiss a proposed class action accusing it of misleading investors about its financial sustainability amid U.S. market pressures, arguing that the suing investors haven't pointed to any specific misrepresentations knowingly made by company executives.
January 11, 2017
A Pennsylvania retirement fund accused Novo Nordisk A/S of hiding increasingly poor financial results from investors in part by colluding with its competitors to raise prices, according to a proposed class action filed in New Jersey federal court Wednesday.